Regional medicine pooling could slash Asean drug costs, expert says

Malaysia's experience with pooled medicine purchasing demonstrates the potential for similar arrangements to reduce healthcare costs across the Asean region, experts said. The domestic savings achieved through consolidated procurement strategies have prompted consideration of expanded cooperation among member states to negotiate better prices and secure more reliable supplies of essential medications.

Policy observers note that coordinated buying power at the regional level could enable Asean nations to leverage stronger negotiating positions with pharmaceutical manufacturers and suppliers. Such an approach would allow individual countries to benefit from economies of scale while addressing shared vulnerabilities in drug availability and pricing.

The proposal reflects growing recognition among regional policymakers that health security and cost control require collaborative mechanisms beyond national borders. Strengthening supply chains through joint procurement could help insulate Asean countries from price volatility and ensure more equitable access to medicines across the region.

Implementing a pooled purchasing system would require establishing common standards, regulatory frameworks, and distribution protocols among participating nations. Regional health officials have signalled openness to exploring such arrangements as part of broader efforts to enhance Asean's healthcare resilience and efficiency.